Agilent opens its Indian biopharma capability center in Hyderabad
The center was inaugurated by Telangana's Minister for Information Technology, Electronics, Communications, and Industries, Duddila Sridhar Babu, in the presence of Agilent's global CEO Padraig McDonnell. Designed to support the entire drug development process, the center features advanced laboratory technologies, expert training, and regulatory-ready workflows to help researchers, scientists, and companies develop high-quality, life-saving medicines. It will serve as a hub for innovation and collaboration, focusing on the development of biologics, biosimilars, and precision medicine.
The facility offers end-to-end solutions across key modalities such as chromatography, mass spectrometry, cell analysis, and lab informatics. These capabilities allow companies to simulate real laboratory environments, test for quality and compliance, and co-create solutions tailored to both Indian and global markets.
For Hyderabad's biopharma startups, academic institutions, and skilled professionals, the center provides access to global expertise, cutting-edge instrumentation, and real-world application environments. It supports accelerated R&D, hands-on training aligned with international regulatory standards, and fosters stronger industry-academia collaboration.
'India is a strategic growth market for Agilent, and Hyderabad is at the forefront of biopharma innovation,' said Padraig McDonnell, CEO of Agilent Technologies. 'Our future will be shaped by continued innovation and a relentless focus on our customers.'
'This new experience center reinforces our support for the 'Make-in-India' initiative by empowering local innovation, nurturing talent, and enabling scalable, affordable, and sustainable solutions,' McDonnell added.
Commenting on the launch, Minister Sridhar Babu said, 'With a strong talent base and a clear focus on innovation, we are building a future-ready healthcare system. The Agilent Biopharma Experience Center is a significant milestone that strengthens Telangana's position as a global life sciences leader and adds value to our growing innovation-driven ecosystem.'
Telangana currently accounts for nearly one-third of India's pharmaceutical production and 40% of bulk drug exports.
Hyderabad boasts one of the most mature and future-focused life sciences ecosystems in India, with deep industry expertise, strong R&D capabilities, and a conducive policy environment. Building on the city's legacy in generics and increasing emphasis on advanced therapies, the new center adds cutting-edge analytical and regulatory capabilities that support local innovation and global delivery.
Earlier this year, Agilent also launched its India Solution Center in Manesar. With this expansion, the company is deepening customer partnerships and positioning India as a strategic hub in its global innovation and growth roadmap.
'Agilent is already working closely with many of India's leading biopharma companies,' McDonnell said. 'With this center, we aim to strengthen those relationships and co-create solutions that address the evolving needs of both Indian and global markets.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
&w=3840&q=100)
Business Standard
14 minutes ago
- Business Standard
Tesla launches first charging station in India at BKC, Mumbai: Details here
Tesla on Monday officially launched its first charging station in India at Mumbai's upscale One BKC in Bandra-Kurla Complex — a significant move that signals the electric automaker's formal entry into the Indian market. The newly operational facility includes four V4 Supercharger stalls (DC fast chargers) and four destination charging stalls (AC chargers). The Superchargers, capable of delivering up to 250 kW, are priced at ₹24 per kWh, while the destination chargers provide 11 kW at ₹14 per kWh. According to Tesla, the Model Y, its debut offering in India, can achieve a range of up to 267 km with just 15 minutes of 'supercharging'. Users can access, monitor, and pay for charging via the Tesla app, which also provides real-time stall availability and charge status notifications. Tesla opens first Indian store in Mumbai The launch follows closely on the heels of Tesla opening its first Indian Experience Centre in Mumbai on July 15. At the facility, the company unveiled the Model Y SUV, which will be sold in two rear-wheel drive variants: a standard model priced at ₹59.89 lakh and a long-range version at ₹67.89 lakh. Both versions are being imported as completely built units (CBUs) from Tesla's Gigafactory in Shanghai. Deliveries are scheduled to begin in the third and fourth quarters of 2025. The US automaker plans to operationalise three more charging locations across Mumbai — in Lower Parel, Thane, and Navi Mumbai — by the end of the September quarter. The expansion is part of a broader strategy to build out EV infrastructure in a market where charging availability remains a critical constraint. Tesla India growth plans While the company's physical presence in India is expanding, its long-term manufacturing strategy remains unclear. Tesla has been in discussions with the Indian government over tax concessions and production incentives, but a definitive commitment to local manufacturing has not been made. In June, ahead of the store opening, Union Minister for Heavy Industries HD Kumaraswamy stated Tesla is currently not inclined to set up manufacturing in India. Import duties continue to be a significant hurdle. India levies up to 70 per cent tax on imported EVs, which inflates the price of Tesla vehicles compared to other markets. For reference, the Model Y starts at $44,990 (approximately ₹37 lakh) in the United States. Nevertheless, Tesla's recent moves indicate a calibrated attempt to tap into India's growing EV ecosystem, driven by increased government focus on green mobility and rising consumer awareness. Tesla sees stiff competition from BYD Globally, the EV major is facing increased pressure, particularly from Chinese competitor BYD, which sold 1.76 million EVs in 2024, just short of Tesla's 1.79 million. India is being seen as a potential growth lever as Tesla looks to diversify amid slowing sales in the US and China. A second Tesla 'Experience Centre' is expected to open in New Delhi later this month.
Business Standard
14 minutes ago
- Business Standard
Dowbox Launches India's Safest Gluten-Free Subscription Box, a Game Changer for Millions Living with Gluten Intolerance or Celiac Disease
India PR Distribution Pune (Maharashtra) [India], August 4: Say hello to Dowbox, India's newest and perhaps most needed subscription box dedicated exclusively to 100% certified gluten-free staples, snacks, flours, mixes, and spices. For the 1 in 10 Indians who are gluten-intolerant and the 1 in 100 who live with celiac disease, Dowbox is not just a product, but a lifeline. Dowbox delivers a curated monthly box of lab-tested, certified gluten-free food products created out of necessity by people living with celiac themselves. The products are safe, clean, affordable, and most importantly, truly free from cross-contamination. "Most products in the Indian market claim to be gluten-free, but in reality, they're produced in facilities where gluten is present, making them unsafe for people who are sensitive to gluten. Their symptoms would return despite eating 'gluten-free'. To address this growing concern, we've launched Dowbox to bring everyday gluten-free pantry essentials and treats, straight to your doorstep, so you can save time and energy spent searching for it," shares the Dowbox founding team. Here's what you get inside your Dowbox: Everyday flours * Gluten-Free Roti flour * Gluten-Free All-Purpose flour * Jowar, Ragi, Rajgira, Varai Bhagar, Yellow Moong Dal, Upwas Bhajani flours Easy mixes * Gluten-Free Split Green Moong Dosa Mix * Dhokla Mix * Bajra Khichda Mix * Chocolate Cake Mix Snacks & cookies * Oreo-style Gluten-Free Chocolick White Cookies * Butter, Coconut, Elaichi & Chocochip Cookies * Gluten-Free Namkeens: Masala Sev, Mathri, Papdi, Namakpare Dowbox also offers gluten-free gift hampers for festivals, birthdays, Diwali, Rakhi, and other special occasions. Bulk and corporate gifting options are also available. Designed for both individuals and families, it offers monthly, quarterly, and yearly subscription plans: * Yearly Plan: Save up to 20% by paying once in a year for monthly boxes * Quarterly Plan: Pay once every quarter for your monthly boxes and save 15% * Monthly Plan: Pay-as-you-go on a month-by-month basis offering 10% savings In recent times, children with behavioral, skin, and gut issues are increasingly being advised a gluten-free diet. At its core, Dowbox stands for affordability, authenticity, and accessibility, with the belief that clean eating should not be a luxury, and that a gluten-free lifestyle should be sustainable, not stressful. Dowbox ships pan-India via its online store The boxes are thoughtfully packed, and delivered monthly to subscribers' doorstep. With the rising awareness around gut health, gluten sensitivity, and autoimmune triggers, Dowbox couldn't have launched at a better time.
&w=3840&q=100)
Business Standard
14 minutes ago
- Business Standard
Tankers deliver barrels of Russian crude to India despite US, EU pressure
India's appetite for discounted Russian crude, and its position as the single largest buyer of Moscow's seaborne oil, has long been a pain point for the US and Western allies Bloomberg By Weilun Soon and Rakesh Sharma At least four tankers discharged millions of barrels of Russian crude at Indian refineries at the weekend, a sign the closely scrutinised deliveries are continuing as normal, even as the US ramps up pressure on the South Asian country to stop purchases. Oil traders and shipping companies have been waiting for direction from New Delhi on whether supplies from Moscow will be allowed to continue after US President Donald Trump last week threatened punitive action to curb trade with Russia. Over the weekend, a senior aide accused India of effectively funding President Vladimir Putin's war in Ukraine. Washington's tough demands, coming after a surprise 25 per cent tariff on Indian exports to the US, threw private and state-owned refineries' purchase plans into disarray. Still, India hasn't asked refiners to stop Russian crude imports, according to people familiar with the matter. Three Aframaxes — the Achilles, Elyte and Horae — unloaded nearly 2.2 million barrels of Urals crude, a key Russian grade, to private processors Nayara Energy Ltd and Reliance Industries Ltd over the weekend after a slight delay, ship-tracking data show. The Mikati, also an Aframax, delivered more than 720,000 barrels of Russia's Varandey crude on a two-stop journey that included deliveries to refineries in Kochi and Mangalore. State-run Bharat Petroleum Corp Ltd owns the Kochi refinery, while Mangalore Refinery and Petrochemicals Ltd. is majority owned by state-run Oil and Natural Gas Corp Ltd. More tankers are poised to discharge another 2.2 million barrels of Urals in the coming hours, with Minion and Destan now at Sikka, a terminal operated by Reliance. Aldebaran is due to unload across the gulf at Mundra. While Bloomberg News couldn't immediately determine the buyer, the Mundra port serves both government-run Indian Oil Corp Ltd. and HPCL-Mittal Energy Ltd, partially owned by state-run Hindustan Petroleum Corp Ltd. Reliance, the largest buyer of Russian Urals, has a long-term deal with Russian producer Rosneft PJSC that would ensure it can get those barrels over several years. India's appetite for discounted Russian crude, and its position as the single largest buyer of Moscow's seaborne oil, has long been a pain point for the US and Western allies. Scrutiny has increased in recent weeks, even before Trump's latest comments. Nayara was sanctioned by the European Union on July 18 for its links to Russia, prompting the processor to cut run rates and pushing trade partners to seek supplies elsewhere.
